Tuesday, April 1, 2014

New test may indicate bladder cancer recurrence

Non-muscle invasive bladder cancer
(NMIBC) is the most common. (Fig.
courtesy of Wikipedia)
MEDICAL NEWS TODAY – Apr. 1, 2014 – A new test that measures a chemical that acts on DNA in many cell processes appears to be highly sensitive in detecting recurrence of the most common form of bladder cancer. Researchers at the University of Southern California, Norris Comprehensive Cancer Center in Los Angeles validated the test on 368 urine samples from 90 bladder cancer patients monitored over seven years. The report in the journal Clinical Cancer Research shows that the new test correctly predicted cancer recurrence 80 percent of the time, and correctly indicated no recurrence 74 percent of the time. Current methods of detecting recurrence in these patients are correct 35 percent of the time and rule out cancer accurately 15 percent of the time.

No comments:

Post a Comment